4.7 Article

Macrophage Migration Inhibitory Factor Promotes Tumor Growth in the Context of Lung Injury and Repair

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1164/rccm.201001-0120OC

Keywords

cytokines; angiogenesis; stroma

Funding

  1. NIH [R01-CA94121, R01-AR48267, R03 AR052482]
  2. Sidney Kimmel foundation
  3. Flight Attendants Medical Research Institute
  4. Michigan Tri-technology corridor MTTC [GR-687]
  5. University of Michigan Cancer Center NIH [CA46592]
  6. Veteran's Administration Research Service
  7. NCI
  8. NIH

Ask authors/readers for more resources

Rationale Tissue injury and repair involve highly conserved processes governed by mechanisms that can be co-opted in tumors. We hypothesized that soluble factors released during the repair response to lung injury would promote orthotopic tumor growth. Objectives: To determine whether lung injury promoted growth of orthotopic lung tumors and to study the molecular mechanisms. Methods: We initiated lung injury in C57BI6 mice using different stimuli, then injected Lewis lung carcinoma cells during the repair phase. We assessed tumor growth 14 days later. We measured tumor angiogenesis, cytokine expression, proliferation, and apoptosis. Measurements and Main Results: Regardless of the mechanism, injured lungs contained more numerous and larger tumors than sham-injured lungs. Tumors from injured lungs were no more vascular, but had higher levels of proliferation and reduced rates of apoptosis. The cytokine macrophage migration inhibitory factor (MIF) was highly expressed in both models of tissue injury. We observed no increase in tumor growth after lung injury in MIF knockout mice. We induced lung-specific overexpression of M IF in a double-transgenic mouse, and observed that MIF overexpression by itself was sufficient to accelerate the growth of orthotopic Lewis lung carcinoma tumors. Conclusions: Lung injury leads to increased expression of the cytokine MIF, which results in protection from apoptosis and increased proliferation in orthotopic tumors injected after the acute phase of injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available